Company Presentation

BioVersys AG

Category:Clinical Stage Company Presentation
Time:16:15 – 16:30
Speaker:Dr. Marc Gitzinger

Company profile

BioVersys AG is a privately owned clinical stage Swiss pharmaceutical company focusing on research and development of small molecules acting on novel bacterial targets with applications in Anti-Microbial Resistance (AMR) and targeted microbiome modulation. With the company’s award-winning TRIC technology we can overcome resistance mechanisms, block virulence production and directly affect the pathogenesis of harmful bacteria, towards the identification of new treatment option

Further information

Follow us